Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 8;9(12):2539.
doi: 10.3390/microorganisms9122539.

Host Immunity and Francisella tularensis: A Review of Tularemia in Immunocompromised Patients

Affiliations
Review

Host Immunity and Francisella tularensis: A Review of Tularemia in Immunocompromised Patients

Olivier Bahuaud et al. Microorganisms. .

Abstract

Tularemia, caused by the bacterium Francisella tularensis, is an infrequent zoonotic infection, well known in immunocompetent (but poorly described in immunocompromised) patients. Although there is no clear literature data about the specific characteristics of this disease in immunocompromised patients, clinical reports seem to describe a different presentation of tularemia in these patients. Moreover, atypical clinical presentations added to the fastidiousness of pathogen identification seem to be responsible for a delayed diagnosis, leading to a" loss of chance" for immunocompromised patients. In this article, we first provide an overview of the host immune responses to Francisella infections and discuss how immunosuppressive therapies or diseases can lead to a higher susceptibility to tularemia. Then, we describe the particular clinical patterns of tularemia in immunocompromised patients from the literature. We also provide hints of an alternative diagnostic strategy regarding these patients. In conclusion, tularemia should be considered in immunocompromised patients presenting pulmonary symptoms or unexplained fever. Molecular techniques on pathological tissues might improve diagnosis with faster results.

Keywords: Francisella tularensis; host immunity; immunocompromised; tularemia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Foley J.E., Nieto N.C. Tularemia. Vet. Microbiol. 2010;140:332–338. doi: 10.1016/j.vetmic.2009.07.017. - DOI - PubMed
    1. Sjöstedt A. Tularemia: History, Epidemiology, Pathogen Physiology, and Clinical Manifestations. Ann. N. Y. Acad. Sci. 2007;1105:1–29. doi: 10.1196/annals.1409.009. - DOI - PubMed
    1. Dennis D.T., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Friedlander A.M., Hauer J., Layton M., et al. Tularemia as a Biological WeaponMedical and Public Health Management. JAMA. 2001;285:2763–2773. doi: 10.1001/jama.285.21.2763. - DOI - PubMed
    1. Maurin M., Gyuranecz M. Tularaemia: Clinical Aspects in Europe. Lancet Infect. Dis. 2016;16:113–124. doi: 10.1016/S1473-3099(15)00355-2. - DOI - PubMed
    1. Ellis J., Oyston P.C.F., Green M., Titball R.W. Tularemia. Clin. Microbiol. Rev. 2002;15:631–646. doi: 10.1128/CMR.15.4.631-646.2002. - DOI - PMC - PubMed

LinkOut - more resources